Infection Screening
Male and female infertility may be influenced by multiple clinical, hormonal, anatomical, environmental, genetic, and infectious factors. Certain reproductive tract infections have been associated with infertility, recurrent pregnancy loss, pelvic inflammatory disease, tubal abnormalities, impaired sperm function, and adverse reproductive outcomes in selected clinical situations.
Some reproductive tract infections may remain asymptomatic for prolonged periods, making early identification clinically challenging in selected individuals.
Microorganisms that may be evaluated in reproductive infection screening workflows include Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Ureaplasma urealyticum, Trichomonas vaginalis, herpes simplex virus (HSV), human papillomavirus (HPV), and Mycobacterium tuberculosis depending on clinical indications and reproductive evaluation protocols.
Certain infections may affect the reproductive tract by contributing to pelvic inflammatory disease, tubal damage, endometrial inflammation, cervical abnormalities, impaired sperm parameters, reduced sperm motility, altered reproductive tract environment, or recurrent reproductive complications depending on the organism involved and clinical condition.
Evaluation may involve clinical assessment, reproductive history, laboratory investigations, reproductive imaging, semen analysis, microbiological testing, and molecular diagnostic techniques depending on the suspected infection and clinical presentation.
Nucleic acid amplification testing (NAAT) and real-time PCR-based molecular diagnostic techniques may assist early identification of selected reproductive pathogens from clinical specimens including semen, urine, cervical swabs, vaginal swabs, urethral swabs, or other reproductive samples depending on the testing protocol.
Infection screening may form part of selected infertility evaluation, recurrent pregnancy loss assessment, reproductive planning, male infertility evaluation, preconception assessment, or assisted reproductive treatment workflows depending on the clinical condition.
Infection screening at Krishna IVF forms part of broader reproductive genetics, molecular diagnostics, reproductive medicine, infertility evaluation, and individualized reproductive healthcare workflows.